This is the third time Vanda has rejected a buyout offer from Future Pak. After its first offer from Future Pak in April, Vanda adopted a shareholder rights plan, known as a "poison pill", to reduce the chances of a hostile takeover.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/h0JOZIu
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment